Womens Health Investment Outlook 2026

Areas prime for investment3 Six opportunity areas reflect a broad spectrum of market maturity and funding potential, underscoring the diversity of the women’s health investment landscape. Building on the landscape analysis, six opportunity areas prime for investment have been identified. This selection combines: (1) analysis of the global health burden across conditions that affect women uniquely, differently or disproportionately; (2) representation from each of these three categories to reflect the breadth of the women’s health market; and (3) insights from stakeholders across the ecosystem. While not exhaustive, these six areas represent prime opportunities for investment, each appealing to different investors based on their priorities across current market activity and future growth potential (e.g. early-, growth- and late- stage investors). Areas prime for investment FIGURE 7 Women dispr oportionately Women dif ferently Women specifically Women’ s cancer therapeutics Biopharmaceutical tr eatments for cancers that uniquely or dispr oportionately af fect women, such as br east, cervical, ovarian, uterine and endometrial cancers; includes targeted antibody-drug conjugates (ADCs), immuno-oncology therapies and other innovations advancing pr ecision medicine. Virtual women’ s healthcar e and benefits management Integrated, digital-first platforms that deliver integrated women’ s health services, including r eproductive, fertility and menopausal car e, thr ough employer - sponsor ed or hybrid car e models. Remote mater nal health monitoring Digital and connected-car e solutions, such as wearables, AI and telehealth, to track key indicators such as glucose, blood pr essur e and foetal health acr oss prenatal and postpartum periods. Women-focused mental health platforms Digital platforms addr essing women’ s unique disor ders, such as PMS, perinatal depr ession, menopause-r elated mood changes and hormonal disor ders. Women-first longevity and wellness concierge services Integrated, pr eventive, hormonal and lifestyle car e models for midlife and postmenopausal women. These of ferings combine medical interventions with wellness services, often supported by concierge-style access and data-driven personalization. Wearable devices and platforms for women’ s metabolic health Wearable technologies and digital health platforms for pr evention and management of conditions such as PCOS, gestational diabetes and insulin resistance, thr ough continuous tracking and behaviour -based coaching. Source: Boston Consulting Group, World Economic Forum Women’s Health Investment Outlook 19